Eltrombopag, a Thrombopoietin Receptor Agonist, Enhances Human Umbilical Cord Blood Hematopoietic Stem/primitive Progenitor Cell Expansion and Promotes Multi-lineage Hematopoiesis

Overview

Journal Stem Cell Res

Publisher Elsevier

Specialty Cell Biology

Date 2012 Jun 12

PMID 22683680

Citations 37

Authors

Hongliang Sun

Ying Tsai

Irena Nowak

Jane Liesveld

Yuhchyau Chen

Affiliations

Soon will be listed here.

Abstract

Umbilical cord blood (UCB) transplantation has emerged as a promising therapy, but it is challenged by scarcity of stem cells. Eltrombopag is a non-peptide, thrombopoietin (TPO) receptor agonist, which selectively activates c-Mpl in humans and chimpanzees. We investigated eltrombopag's effects on human UCB hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) expansion, and its effects on hematopoiesis in vivo. Eltrombopag selectively augmented the expansion of human CD45+, CD34+, and CD41+ cells in bone marrow compartment without effects on mouse bone marrow cells in the NOD/SCID mice xenotransplant model. Consequently, eltrombopag increased peripheral human platelets and white blood cells. We further examined effects in the STAT and AKT signaling pathways in serum-free cultures. Eltrombopag expanded human CD34+ CD38-, CD34+, and CD41+ cells. Both eltrombopag and recombinant human TPO (rhTPO) induced phosphorylation of STAT5 of CD34+ CD41-, CD34- CD41+, and CD34- CD41- cells. rhTPO preferentially induced pSTAT3, pAKT, and more pSTAT5 in CD34- C41+ cells, while eltrombopag had no effects on pSTAT3. In conclusion, eltrombopag enhanced expansion of HSCs/HPCs of human UCB in vivo and in vitro, and promoted multi-lineage hematopoiesis through the expansion of bone marrow HSCs/HPCs of human UCB in vivo. Eltrombopag differed somewhat from rhTPO in the signal transduction pathways by favoring earlier HSC/HPC populations.

Citing Articles

Identification of key immune-related genes and potential therapeutic drugs in diabetic nephropathy based on machine learning algorithms.

Guo C, Wang W, Dong Y, Han Y BMC Med Genomics. 2024; 17(1):220.

PMID: 39187837 PMC: 11348758. DOI: 10.1186/s12920-024-01995-4.

Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence.

Li X, Shangguan X, Wang H, Wang Q, Zhang Y, Han B Ann Hematol. 2024; 103(9):3483-3491.

PMID: 39088061 DOI: 10.1007/s00277-024-05910-w.

Expansion of Haematopoietic Stem and Progenitor Cells: Paving the Way for Next-Generation Haematopoietic Stem Cell Transplantation.

Bari S, Chong P, Hwang W Blood Cell Ther. 2023; 2(4):58-67.

PMID: 37588101 PMC: 10427230. DOI: 10.31547/bct-2019-004.

In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation.

Bozhilov Y, Hsu I, Brown E, Wilkinson A Cells. 2023; 12(6).

PMID: 36980237 PMC: 10046976. DOI: 10.3390/cells12060896.

Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells.

Muntion S, Preciado S, Sanchez-Luis E, Corchete L, Diez-Campelo M, Osugui L Ther Adv Hematol. 2023; 13:20406207221142137.

PMID: 36601635 PMC: 9806379. DOI: 10.1177/20406207221142137.

References

Ramsfjell V, Borge O, Cui L, Jacobsen S . Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and flt3, and inhibitory.... J Immunol. 1997; 158(11):5169-77. View

Barker J, Krepski T, DeFor T, Davies S, Wagner J, Weisdorf D . Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002; 8(5):257-60. DOI: 10.1053/bbmt.2002.v8.pm12064362. View

Nishino T, Miyaji K, Ishiwata N, Arai K, Yui M, Asai Y . Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL. Exp Hematol. 2009; 37(11):1364-1377.e4. DOI: 10.1016/j.exphem.2009.09.001. View

Barker J, Weisdorf D, DeFor T, Blazar B, Miller J, Wagner J . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003; 102(5):1915-9. DOI: 10.1182/blood-2002-11-3337. View

Erickson-Miller C, Delorme E, Tian S, Hopson C, Landis A, Valoret E . Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist. Stem Cells. 2008; 27(2):424-30. PMC: 2729672. DOI: 10.1634/stemcells.2008-0366. View

Larochelle A, Vormoor J, Hanenberg H, Wang J, Bhatia M, Lapidot T . Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996; 2(12):1329-37. DOI: 10.1038/nm1296-1329. View

Nogami W, Yoshida H, Koizumi K, Yamada H, Abe K, Arimura A . The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica. 2008; 93(10):1495-504. DOI: 10.3324/haematol.12752. View

Inagaki K, Oda T, Naka Y, Shinkai H, Komatsu N, Iwamura H . Induction of megakaryocytopoiesis and thrombocytopoiesis by JTZ-132, a novel small molecule with thrombopoietin mimetic activities. Blood. 2004; 104(1):58-64. DOI: 10.1182/blood-2003-10-3623. View

Borge O, Ramsfjell V, Cui L, Jacobsen S . Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin. Blood. 1997; 90(6):2282-92. View

10.

Yoshihara H, Arai F, Hosokawa K, Hagiwara T, Takubo K, Nakamura Y . Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell. 2008; 1(6):685-97. DOI: 10.1016/j.stem.2007.10.020. View

11.

Will B, Kawahara M, Luciano J, Bruns I, Parekh S, Erickson-Miller C . Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome. Blood. 2009; 114(18):3899-908. PMC: 2773490. DOI: 10.1182/blood-2009-04-219493. View

12.

Qian H, Buza-Vidas N, Hyland C, Jensen C, Antonchuk J, Mansson R . Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell. 2008; 1(6):671-84. DOI: 10.1016/j.stem.2007.10.008. View

13.

Rocha V, Wagner Jr J, Sobocinski K, Klein J, Zhang M, Horowitz M . Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000; 342(25):1846-54. DOI: 10.1056/NEJM200006223422501. View

14.

Ballen K, Spitzer T, Yeap B, McAfee S, Dey B, Attar E . Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. 2007; 13(1):82-9. PMC: 2947324. DOI: 10.1016/j.bbmt.2006.08.041. View

15.

Farese A, Hunt P, Grab L, MacVittie T . Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 1996; 97(9):2145-51. PMC: 507290. DOI: 10.1172/JCI118652. View

16.

Bussel J, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L . Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet. 2009; 373(9664):641-8. DOI: 10.1016/S0140-6736(09)60402-5. View

17.

Chao N, Emerson S, Weinberg K . Stem cell transplantation (cord blood transplants). Hematology Am Soc Hematol Educ Program. 2004; :354-71. DOI: 10.1182/asheducation-2004.1.354. View

18.

Koestenbauer S, Zisch A, Dohr G, Zech N . Protocols for hematopoietic stem cell expansion from umbilical cord blood. Cell Transplant. 2009; 18(10):1059-68. DOI: 10.3727/096368909X471288. View

19.

Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel K, Broudy V . Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol. 1996; 24(2):265-9. View

20.

Fukushima-Shintani M, Suzuki K, Iwatsuki Y, Abe M, Sugasawa K, Hirayama F . AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Eur J Haematol. 2009; 82(4):247-54. DOI: 10.1111/j.1600-0609.2008.01198.x. View